What You Should Know:
- MedArrive, a Mobile-integrated care management platform company today announced $8M in new funding led by Cobalt Ventures, a wholly owned subsidiary of Blue Cross and Blue Shield of Kansas City (Blue KC). The investment follows MedArrive’s $25 million series A round in November 2021 and brings the company’s total funding to $40.5M to date
- MedArrive plans to use the new investment to expand its payer relationships, build out its team and
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Exec Hires: COTA Appoints First Chief Commercial Officer
What You Should Know:
- COTA, Inc., an oncology real-world data and analytics company, today announced the appointment of Sandy Leonard as its first Chief Commercial Officer.
- As CCO, Sandy will drive COTA’s life sciences growth strategy, prioritizing customer success and experience. More specifically, she will lead a team that is laser-focused on ensuring that pharmaceutical partners have the data assets, analytics, services, and support they need to develop life-saving
Read More
Audio-Only Telehealth Remains Common at Safety Net Clinics, Study Finds
What You Should Know:
Audio-only telehealth visits for both primary care and mental health services remained common at safety net clinics in California since the start of the COVID-19 pandemic, according to a new RAND Corporation study.
The RAND study published in the Journal of the American Medical Association found that in August 2022 audio-only visits still accounted for 1 in 5 primary care visits and 2 in 5 behavioral health visits among people who received care at Federally
Read More
Thinking Beyond CRM to Reach Healthcare Consumers
A new type of purpose-built technology is necessary to manage patient relationships.
Customer relationship management (CRM) systems are commonplace in nearly every industry, though their use in healthcare is complicated. Healthcare is incredibly complex and unique in many ways, and many generic CRM or CRM-like solutions address only one or two elements of the patient journey, such as appointment scheduling and reminders, without factoring in personal needs and preferences, health histories,
Read More
Optimizing Patient Experience: How Virtual Offerings are Changing The Healthcare Climate As We Know It
Providing patients with a positive health outcome is always the priority for their healthcare provider. The journey to accomplishing this goal can often be an uphill challenge with many variables at play. Providers are tasked with not only delivering a positive health outcome but also with the patient experience and level of satisfaction as they make their way through their healthcare journey. Since the Covid-19 pandemic and the emergence of virtual healthcare, the healthcare industry has
Read More
FDA & Cerner Enviza Collaborate to Develop AI Tools for Drug Safety
What You Should Know:
- Cerner Enviza, an Oracle company, and FDA’s Sentinel Innovation Center are teaming up to develop AI tools to extract and assess clinical notes to better understand drug safety.
- Teaming with John Snow Labs, Cerner Enviza will use AI and NLP to develop tools to extract information from clinical notes within the EHR to better aid in better understanding the effects of medicines on large populations. The project known as the Multi-source Observational
Read More
Clearday and Viveon Health Merge to Create Longevity Care Company
What You Should Know:
- Clearday, an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp., a special purpose acquisition (SPAC) company have entered into a definitive merger agreement.
- The combined company's pro forma equity valuation (assuming no share redemptions) is expected to be approximately $370M. VHAQ currently has $20M held in a trust
Read More
HeartFlow Raises $215M for AI-Powered Cardiac Test
What You Should Know:
- HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management.
- HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary
Read More
PsychoGenics Launches AI Platform to Revolutionize Drug Discovery
What You Should Know:
- PsychoGenics Inc., a provider of AI-enabled phenotypic drug discovery and preclinical CRO services launches eCube®, a novel pharmaco-electroencephalography (“pharmacoEEG”) platform.
The platform supports phenotypic drug discovery, which unlike traditional target-based drug discovery, can identify novel treatments with multiple targets.
How eCube Works
eCube measures drug-induced changes to EEG spectra data and utilizes machine learning classifiers trained
Read More
Exec Hires: Clinical Trials Marketplace SubjectWell Appoints New CEO
What You Should Know:
- SubjectWell, the largest engagement platform for matching patients with chronic health conditions to new care options, announced that clinical industry veteran Fred Martin has joined SubjectWell as CEO.
- Fred will joins SubjectWell during a time of growth following the company’s Series B funding in November 2022, with the goal of accelerating technical solutions and building investor relations.
Fred Martin Bio
Fred brings more than 25 years of experience in
Read More
